Dividend-adjusted total return · S&P 500 uses VOO · Dec 31, 2025 – Nov 5, 2026KURES&P 500 · VOOThematic average
KraneShares MSCI All China Health Care Index ETFKURE
$18.73
+0.5% last session
+9.9% YTD
Data as of 11/5/20264:00 PM ET · End-of-day
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | +0.5% | −2.0% | +1.0% | +9.9% | +3.8% | +8.3% | −35.8% | −7.6% |
| Peer average | −0.2% | −3.5% | −12.4% | −11.6% | −12.9% | +25.3% | −24.5% | — |
| S&P 500 · VOO | −4.4% | −5.7% | −4.9% | +8.4% | +9.8% | +82.2% | +71.6% | — |
Key Statistics
Open all fund facts →- AUM
- $113M
- Expense ratio
- 0.79%
- Distribution yield
- 3.8%
- NAV
- $18.32
- Volume
- 70K
- Avg. volume 30D
- 103K
- High today
- $19.11
- Low today
- $18.61
- Previous close
- $18.63
- 52-week high
- $19.93
- 52-week low
- $14.38
- Our risk indicator
- 4/5
KURE in One Breath
KURE Among China ETFs
YTDEnd-of-day Nov 6, 2026 · 25 China ETFs by YTD
$10,000 in KURE
5Y$10,000 in KURE became
$6,419
In the S&P 500 (VOO)
$17,156
Total return, dividends in · Oct 28, 2021 – Nov 5, 2026 · S&P 500 uses VOO
KURE’s Top Holdings
Today6160.HKBeone Medicines9.0%1801.HK8.1%2269.HK7.6%603259.SS5.6%600276.SS4.6%300760.SZ4.5%9926.HK3.9%1177.HK3.7%1093.HK3.4%2359.HK3.2%3692.HK3.1%1548.HK2.8%000538.SZ2.5%688271.SS2.5%300015.SZ2.1%1530.HK2.1%6990.HK2.0%600436.SS2.0%002422.SZ1.9%300759.SZ1.7%1099.HK1.6%31 more
6160.HKBeone Medicines9.0%1801.HK8.1%2269.HK7.6%603259.SS5.6%600276.SS4.6%300760.SZ4.5%9926.HK3.9%1177.HK3.7%1093.HK3.4%2359.HK3.2%3692.HK3.1%41 more
BiotechnologyDrug Manufacturers - SpecialtyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - DevicesMedical - PharmaceuticalsOther
KraneShares KURE · 53 holdings · tile size = share of the fund · as of Nov 5, 2026
What KURE Holds
TodayBiotechnology39.9%
6160.HK 9.0 · 1801.HK 8.1 · 2269.HK 7.6 · 9926.HK 3.9 · 1548.HK 2.8 · 1530.HK 2.1 · 6990.HK 2.0
Drug Manufacturers - Specialty & Generic10.2%
600276.SS 4.6 · 3692.HK 3.1 · 000538.SZ 2.5
Medical - Diagnostics & Research8.8%
603259.SS 5.6 · 2359.HK 3.2
Drug Manufacturers - General5.4%
1093.HK 3.4 · 600436.SS 2.0
Medical - Devices4.5%
300760.SZ 4.5
Medical - Pharmaceuticals3.7%
1177.HK 3.7
Medical - Specialties2.5%
688271.SS 2.5
KraneShares KURE · share of the fund by industry · as of Nov 5, 2026
Beone’s Share of KURE
Today9.0%
$90 of every $1,000 in KURE is Beone
Beone held by KURE
$10.1M
KraneShares KURE · each square = $10 of $1,000 · as of Nov 5, 2026
KURE’s Share of China ETFs
Today0.6%
of the $19.3B in 25 China ETFs
$113M0.6%
$5.8B30.0%
$4.4B23.0%
$8.9B46.3%
China ETF AUM · Nov 6, 2026
KURE Fee per $100 vs Peers
TodayExpense ratio · China peers · Nov 6, 2026
Inside KURE
53 holdings · as of Nov 5, 2026KURE
KraneShares MSCI All China Health Care Index ETF
TodayBiotechnology39.9%6160.HKBeone Medicines9.0%1801.HK8.1%2269.HK7.6%9926.HK3.9%1548.HK2.8%Drug Manufacturers - Specialty10.2%600276.SS4.6%3692.HK3.1%000538.SZ2.5%Medical - Diagnostics8.8%603259.SS5.6%Drug Manufacturers - General5.4%1093.HK3.4%Medical - Devices4.5%300760.SZ4.5%Medical - Pharmaceuticals3.7%1177.HK3.7%Medical - Specialties2.5%688271.SS2.5%Medical - Care Facilities2.1%Medical - Distribution1.6%Other21.4%5 more
Biotechnology39.9%6160.HK9.0%1801.HK8.1%2269.HK7.6%9926.HK3.9%4 moreDrug Manufacturers - Specialty10.2%600276.SS4.6%Medical - Diagnostics8.8%603259.SS5.6%Drug Manufacturers - General5.4%Medical - Devices4.5%300760.SZ4.5%Medical - Pharmaceuticals3.7%1177.HK3.7%Medical - Specialties2.5%Medical - Care Facilities2.1%Other21.4%13 more
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | 6160.HK | Beone Medicines | 8.96% |
| 2 | 1801.HK | Innovent Biologics | 8.05% |
| 3 | 2269.HK | Wuxi Biologics Cayman | 7.55% |
| 4 | 603259.S | Wuxi Apptec -A | 5.60% |
| 5 | 600276.S | Jiangsu Hengrui Pharmaceut-a | 4.60% |
| 6 | 300760.S | Shenzhen Mindray Bio-medic-a | 4.45% |
| 7 | 9926.HK | Akeso | 3.90% |
| 8 | 1177.HK | Sino Biopharmaceutical | 3.67% |
| 9 | 1093.HK | Cspc Pharmaceutical Group LT | 3.44% |
| 10 | 2359.HK | Wuxi Apptec -H | 3.25% |
BiotechnologyDrug Manufacturers - SpecialtyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - DevicesMedical - PharmaceuticalsMedical - SpecialtiesMedical - Care FacilitiesMedical - DistributionOther
KraneShares KURE · current holdings by weight · as of Nov 5, 2026 · each tile is one holding · top 20 = 76.1%
All KURE Holdings
45 holdings · as of Nov 5, 2026KURE
KURE’s Holdings
Today| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 6160.HKBeone Medicines | Healthcare | 8.96% | $896.22 | 342K | $10.1M |
| 2 | 1801.HKInnovent Biologics | Healthcare | 8.05% | $805.43 | 837K | $9.1M |
| 3 | 2269.HKWuxi Biologics Cayman | Healthcare | 7.55% | $755.08 | 1.4M | $8.5M |
| 4 | 603259.SSWuxi Apptec | Healthcare | 5.60% | $560.09 | 283K | $6.3M |
| 5 | 600276.SSJiangsu Hengrui Pharmaceut | Healthcare | 4.60% | $460.17 | 705K | $5.2M |
| 6 | 300760.SZShenzhen Mindray Bio-medic | Healthcare | 4.45% | $445.35 | 185K | $5.0M |
| 7 | 9926.HKAkeso | Healthcare | 3.90% | $390.18 | 418K | $4.4M |
| 8 | 1177.HKSino Biopharmaceutical | Healthcare | 3.67% | $367.14 | 6.3M | $4.1M |
| 9 | 1093.HKCspc Pharmaceutical Group LT | Healthcare | 3.44% | $344.01 | 3.6M | $3.9M |
| 10 | 2359.HKWuxi Apptec -H | Healthcare | 3.25% | $324.69 | 145K | $3.7M |
| 11 | 3692.HKHansoh Pharmaceutical Group | Healthcare | 3.10% | $309.61 | 802K | $3.5M |
| 12 | 1548.HKGenscript Biotech | Healthcare | 2.77% | $276.98 | 720K | $3.1M |
| 13 | 000538.SZYunnan Baiyao Group | Healthcare | 2.48% | $248.06 | 339K | $2.8M |
| 14 | 688271.SSShanghai United Imaging He | Healthcare | 2.46% | $246.25 | 157K | $2.8M |
| 15 | 300015.SZAier EYE Hospital Group | Healthcare | 2.10% | $210.15 | 1.8M | $2.4M |
KraneShares KURE · every reported holding · per $10,000 = dollars of each holding in a $10,000 stake · as of Nov 5, 2026
How It Compares
KURE
KraneShares MSCI All China Health Care Index ETF’s Peers
YTDChina peers · YTD and past-year returns · as of Nov 6, 2026 · sorted by AUM
Head to Head
Put KURE head to head with MCHI →MCHI vs KURE
YTDYear to date
KURE wins+22.7 pts
Past year
KURE wins+19.2 pts
Fee
MCHI winslower fee
Yield
KURE wins+1.7 pts
AUM
MCHI51.4× more
3–1KURE wins
iShares MCHI and KraneShares KURE · year-to-date · as of Nov 6, 2026 · AUM not scored
China vs Thematic
Average · YTDMCHI
−12.8%
KURE
+9.9%
Thematic average
+2.3%
MCHI, KURE and the average thematic ETF · YTD return · as of Nov 6, 2026
KURE vs VOO
YTDKURE · KraneShares MSCI All China Health Care Index
+9.9%
VOO · S&P 500
+8.4%
Gap
1.5 pts
KraneShares KURE and Vanguard VOO · YTD total return · as of Nov 6, 2026
KURE vs Its Peer Average
YTDKUREAvsBPeer average
1D+0.5%−0.2%
1M−2.0%−3.5%
3M+1.0%−12.4%
YTD+9.9%−11.6%
1Y+3.8%−12.9%
3Y+8.3%+25.3%
5Y−35.8%−24.5%
5–2KURE wins
24 China peers · each row scaled to its leader
The Details
KURE
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y28.08%
Deepest drop · 1Y−24.6%
Lowest point · 5Y−57.6%
52-week range
$18.73
$14.38−6.0% from the high$19.93
KraneShares KURE · past-year price moves · as of Nov 6, 2026
KURE
Fund Facts
Today2018launched Jan 31
Tracks[…]
Exchange · CUSIPAMEX · 500767835
StructureETF
Leverage1x
Cost on $10,000$79 a year
Go deeper
KraneShares KURE · fund facts · as of Nov 6, 2026
KURE
Payouts by Year
8Y$0.71per share, Dec 2025
Distribution yield3.8%
PaidOnce a year, in December
Latest ex-date · paidDec 22 · Dec 23, 2025
8 payouts added up$5.21 a share
KraneShares KURE · distributions by ex-date · 2018–2025
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-03-31 ↗SEC reported portfolio · 2025-12-31 ↗SEC reported portfolio · 2025-09-30 ↗SEC reported portfolio · 2025-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-03-31 ↗SEC reported portfolio · 2024-12-31 ↗SEC reported portfolio · 2024-09-30 ↗SEC reported portfolio · 2024-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-03-31 ↗SEC reported portfolio · 2023-12-31 ↗SEC reported portfolio · 2023-09-30 ↗SEC reported portfolio · 2023-06-30 ↗summary prospectus · SEC 497K ↗
Trading & Liquidity
Net asset value$18.32
Premium / discount[…]
Median spread · 30D[…]
Volume today70K
Average volume · 30D103K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.79%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$79.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 23, 2025 | $0.71 |
| Dec 17, 2024 | Dec 18, 2024 | $0.18 |
| Dec 18, 2023 | Dec 20, 2023 | $0.11 |
| Dec 28, 2022 | Dec 30, 2022 | $0.0104 |
| Dec 29, 2021 | Dec 31, 2021 | $4.05 |
| Dec 29, 2020 | Dec 31, 2020 | $0.0001 |
| Dec 27, 2019 | Dec 31, 2019 | $0.0573 |
| Dec 26, 2018 | Dec 28, 2018 | $0.0760 |
Issuer contentFrom KraneSharesHear the strategy from the people behind KURE.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →